London 17 June 2009 – Ark Therapeutics Group Plc (“Ark” or “the Company”) announces today that it has signed an agreement with the privately owned global woundcare company, AOTI Ltd. (AOTI), for the supply of Kerraboot in conjunction with...
Galway, Ireland, May 26- AOTI announced today that a new clinical study published in the May issue of European Journal of Vascular and Endovascular Surgery demonstrates superior wound closure rates for patients suffering from refractory venous ulcers treated with its...
Galway, Ireland, May 5- AOTI, INC., announced today that Dr. Christian Frye has joined the company as its Global Medical Director and Chief Science Officer. Christian graduated from the University of Cologne, Germany in 1994 with his Medical Degree and has more than...
Galway, Ireland, April 15- AOTI announced today the release of its new enhanced multi-size Single Patient Use Sacral Units. “AOTI continues to listen to our customers and make enhancements to our products”, stated Mike Griffiths President and CEO, “our new multi-size...
Galway, Ireland, April 1- AOTI, INC., announced today that Gerry Coughlan has joined the company as Vice President of Operations and Manufacturing at the company’s Galway, Ireland facility. Gerry graduated has spent nearly 20 years in the medical device business in...
